Arno Therapeutics, Inc.
ARNI
$0.0001
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | 09/30/2015 | |
|---|---|---|---|---|---|
| Net Income | -13.70M | -10.53M | -11.83M | -11.51M | -2.95M |
| Total Depreciation and Amortization | 7.20K | 7.20K | 7.20K | 7.60K | 8.90K |
| Total Amortization of Deferred Charges | 12.50K | 12.50K | 12.50K | 2.40K | -- |
| Total Other Non-Cash Items | 6.62M | 2.32M | 2.83M | 1.55M | -7.72M |
| Change in Net Operating Assets | -560.50K | -533.10K | -633.40K | -19.70K | -787.40K |
| Cash from Operations | -7.62M | -8.72M | -9.61M | -9.97M | -11.45M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 1.60K | 800.00 | 0.00 | 0.00 |
| Total Debt Issued | 2.10M | 2.10M | 2.10M | 2.10M | -- |
| Total Debt Repaid | -3.70K | -3.50K | -3.40K | -3.30K | -2.70K |
| Issuance of Common Stock | 7.63M | 5.28M | 5.28M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.20K | -80.80K | -15.00K | -12.50K | -- |
| Cash from Financing | 9.62M | 7.29M | 7.36M | 2.08M | -2.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.00M | -1.43M | -2.25M | -7.88M | -11.45M |